2016 has marked 100 years since the landmark description of what we now know as Guillain–Barré syndrome (GBS). Goodfellow and Willison chart the great progress we have made in understanding the pathogenesis of GBS, and developing established and emerging therapies.
- John A. Goodfellow
- Hugh J. Willison
